COVID-19 has dominated conversations about public health in the past three years, causing respiratory tract infections in people. Now, a different respiratory virus, Human Metapneumovirus (HMPV), is surging in Australia and causing respiratory disease, particularly in New South Wales.
This lesser-known virus has been monitored since the early 2000s, but recent data shows a notable spike, with weekly cases soaring from 648 to 1,168 in September. Typically prevalent in late winter and spring, this unusual increase has raised concerns. Understanding HMPV and its current prevalence becomes crucial as the world shifts from COVID-19.
Who Are at Risk of Human Metapneumovirus
HMPV is a respiratory virus commonly found circulating in late winter and spring in Australia. Individuals at greater risk of severe cases include young children, the elderly, and those with compromised immune systems.
Since the onset of the COVID-19 pandemic, there has been an uptick in the detection of respiratory viruses, including HMPV, as highlighted by Nusrat Homaira, a respiratory epidemiologist at the University of New South Wales.
HMPV, much like other respiratory illnesses, can exhibit varying levels of severity. While it typically results in mild upper respiratory tract infections, it can escalate to more serious conditions like pneumonia.
John-Sebastian Eden, a senior research fellow at the University of Sydney, emphasizes the significance of taking HMPV seriously, particularly for teenagers and adults who may experience severe respiratory issues. Although it can be fatal, for most individuals, it presents as a severe respiratory illness.
Eden suggests that HMPV is likely circulating in other Australian states, particularly along the East Coast. Paul Griffin, director of infectious diseases at Mater Health Services in Queensland, warns that the virus has a propensity to trigger outbreaks in nursing homes and hospitals.
Therefore, early case identification is crucial. He also underscores the importance of taking precautions if experiencing illness, even if tests for COVID, flu, and RSV come back negative. Griffin recommends considering a comprehensive respiratory virus PCR panel from a laboratory to pinpoint the specific infection.
Symptoms, Prevention, and Treatment
HMPV as a virus that causes respiratory disease exhibits symptoms strikingly similar to those of a common cold, such as coughing, wheezing, shortness of breath, and nasal congestion. This makes it challenging to distinguish from COVID-19, the flu, or respiratory syncytial virus (RSV), which shares genetic similarities with HMPV.
Many people may not even be aware of HMPV until they receive a positive test result, as it often eludes detection. Testing for HMPV typically involves a PCR (polymerase chain reaction) test, though not all PCRs are designed to specifically identify HMPV.
To combat the rising cases of HMPV, NSW Health has issued a series of precautionary measures. These include staying at home when displaying cold or flu symptoms, regularly sanitizing or washing hands, wearing masks in crowded indoor environments, opting for outdoor gatherings or well-ventilated spaces, and refraining from visiting individuals at higher risk of severe illness when symptomatic.
Professor William Rawlinson, a virologist at the University of New South Wales, emphasizes the widespread agreement in the medical community about the effectiveness of masks in slowing the spread of respiratory illnesses. However, he suggests that a combination of strategies is needed.
Dr. Eden underscores that there are currently no antiviral drugs or vaccines available for treating HMPV. The primary approach is to manage symptoms and allow the immune system to combat the virus. He advises individuals to stay home when sick, maintain proper hygiene, and avoid close contact with others when experiencing respiratory infections. The key is rest and hydration.
RELATED ARTICLE: Researchers Warn That Respiratory Diseases Has Higher Rate Than Coronavirus During Winter
Check out more news and information on Medicine and Health in Science Times.
